Showing 421 - 440 results of 36,075 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 10 ((nn decrease) OR (mean decrease)) ))', query time: 0.63s Refine Results
  1. 421
  2. 422
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431

    Adjusted<sup>a</sup> mean decrease in days elapsed in the cascade of HCC care post-intervention. by Yapei Zhang (6416108)

    Published 2022
    “…<p>Adjusted<a href="/article/info:doi/10.1371/journal.pdig.0000080#t004fn001" target="_blank"><sup>a</sup></a> mean decrease in days elapsed in the cascade of HCC care post-intervention.…”
  12. 432
  13. 433
  14. 434
  15. 435

    Hematopoietic-restricted loss of Zeb1 decreases hematopoietic colony formation potential and ability to compete with wt HSPCs for contribution to all hematopoietic lineages. by Jueqiong Wang (11467505)

    Published 2021
    “…<p><b>(A)</b> HSPCs isolated from Vav-iCre; <i>Zeb1</i><sup>fl/fl</sup> fetal livers show decreased numbers of colonies in methylcellulose-based colony assays (first) that further decreases upon secondary replating (second) compared to Cre negative controls. …”
  16. 436

    Longer <i>L</i><sub><i>u</i></sub> significantly decreases and delays the peak of the sound-evoked CAPs of SGN fibers. by Maral Budak (6680351)

    Published 2021
    “…<p>(A) Sound-evoked CAPs of SGN fiber populations with varying unmyelinated segment length <i>L</i><sub><i>u</i></sub> at 70dB SPL, averaged over 50 simulations. …”
  17. 437

    Longer <i>L</i><sub><i>h</i></sub> significantly decreases and delays the peak of the sound-evoked CAPs of SGN fibers. by Maral Budak (6680351)

    Published 2021
    “…<p>(A) Sound-evoked CAPs of SGN fiber populations of varying heminode length <i>L</i><sub><i>h</i></sub> at 70dB SPL, averaged over 50 simulations. …”
  18. 438
  19. 439
  20. 440

    DataSheet_1_Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.docx by Taotao Liang (9944552)

    Published 2022
    “…<p>T cell immune dysfunction is a prominent characteristic of chronic lymphocytic leukemia (CLL) and the main cause of failure for immunotherapy and multi-drug resistance. …”